Latest articles

Cardinal Health is pleased to announce an agreement with TerraPower that will help advance the next generation of cancer treatment. Working together, the companies will develop and produce...

New tool is designed to help pharmacies navigate state-by-state interchangeability laws for the FDA’s new regulatory designation Cardinal Health has created an interactive tool that provides...

Change has been the one constant in nuclear medicine from the beginning, with the steady arrival of new radiopharmaceuticals, new technologies and an evolving regulatory environment. Today, as...

Our chief strategy officer, Michele Holcomb, spoke with Forbes about the deep connection between diversity, equity and inclusion (DE&I) and innovation. “My view of innovation was formed early in...

In December 2020, the FDA announced that a new radioactive diagnostic agent, Gallium 68 (Ga-68) PSMA-11, could be prescribed and administered to patients with suspected prostate cancer metastasis...

Cardinal Health has been named one of the 2021 Best Companies for Multicultural Women by Seramount (formerly Working Mother Media), an honor recognizing companies that create and use best...

Last year, a critical need for life-saving blood and plasma donations arose with two major complications: an extraordinary decrease in blood donations due to the COVID-19 pandemic, and...

By Victor Crawford, Chief Executive Officer, Pharmaceutical Segment Today, our network of thousands of community pharmacy customers passed an important milestone: Collectively, they have...

By Tiffany Olson, president of Nuclear & Precision Health Solutions at Cardinal Health From HealthCare Business News magazine: Precision medicine is an area of healthcare that targets treatment...

A long-time Cardinal Health pharmacy customer inspires the development of MyScheduling software Like many pharmacists across the country, Jana Bennett, RPh, head pharmacist at a Medicine Shoppe...